While the precise interplay of these mechanisms is still being investigated, the result is significant weight loss observed in obese patients participating in tesofensine trials
J Clin Invest (1983) 72(3):115062
McIntyre RS, Mansur RB, Rosenblat JD, Kwan ATH (2024) The association between glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: reports to the Food and Drug Administration Adverse Event Reporting System (FAERS)
Un informe (en ingls) del 2017 en The Lancet sigui a 1,505 personas que usaron liraglutida (Victoza, Saxenda) y a 749 que tomaron un placebo
Safe, sustainable reduction often occurs over 612 months depending on starting weight and consistency
"I just wanted to get to my best self - to show them what a healthy mum looks like